RXi Pharmaceuticals to Present at the 10th Annual Biotech Showcase Conference

December 29, 2017

Responsive image

MARLBOROUGH, Mass., Dec. 29, 2017 /PRNewswire/ — RXi Pharmaceuticals Corporation (NASDAQ: RXII) a clinical-stage company developing a new class of RNAi-based therapeutics today announced that the Company’s President and CEO, Dr. Geert Cauwenbergh, will present at the 10th Annual Biotech…

Category: Precious Metals